首页> 美国卫生研究院文献>other >Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration
【2h】

Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration

机译:通过IL-4洗脱涂层在生物材料界面处巨噬细胞表型的变化与改善的植入物整合性有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The present study tests the hypothesis that transient, early-stage shifts in macrophage polarization at the tissue-implant interface from a pro-inflammatory (M1) to an anti-inflammatory/regulatory (M2) phenotype mitigates the host inflammatory reaction against a non-degradable polypropylene mesh material and improves implant integration downstream. To address this hypothesis, a nanometer-thickness coating capable of releasing IL-4 (an M2 polarizing cytokine) from an implant surface at early stages of the host response has been developed. Results of XPS, ATR-FTIR and Alcian blue staining confirmed the presence of a uniform, conformal coating consisting of chitosan and dermatan sulfate. Immunolabeling showed uniform loading of IL-4 throughout the surface of the implant. ELISA assays revealed that the amount and release time of IL-4 from coated implants were tunable based upon the number of coating bilayers and that release followed a power law dependence profile. In-vitro macrophage culture assays showed that implants coated with IL-4 promoted polarization to an M2 phenotype, demonstrating maintenance of IL-4 bioactivity following processing and sterilization. Finally, in-vivo studies showed that mice with IL-4 coated implants had increased percentages of M2 macrophages and decreased percentages of M1 macrophages at the tissue-implant interface during early stages of the host response. These changes were correlated with diminished formation of fibrotic capsule surrounding the implant and improved tissue integration downstream. The results of this study demonstrate a versatile cytokine delivery system for shifting early-stage macrophage polarization at the tissue-implant interface of a non-degradable material and suggest that modulation of the innate immune reaction at early stages of the host response may represent a preferred strategy for promoting biomaterial integration and success.
机译:本研究测试了以下假设:组织-种植体界面巨噬细胞极化从促炎(M1)到抗炎/调节(M2)表型的瞬时,早期转变减轻了宿主针对非炎症反应的炎症反应。可降解聚丙烯网状材料,并改善下游的植入物整合性。为了解决该假设,已经开发了能够在宿主反应的早期从植入物表面释放IL-4(M2极化细胞因子)的纳米厚度涂层。 XPS,ATR-FTIR和阿尔辛蓝染色的结果证实存在由壳聚糖和硫酸皮肤素组成的均匀,保形的涂层。免疫标记显示在整个植入物表面均匀加载IL-4。 ELISA分析显示,基于包被双层的数量,从包被的植入物中IL-4的数量和释放时间是可调的,并且释放遵循幂律依赖性曲线。体外巨噬细胞培养测定表明,涂有IL-4的植入物将极化促进为M2型,表明在加工和灭菌后IL-4生物活性得以维持。最后,体内研究表明,在宿主反应的早期,具有IL-4涂层植入物的小鼠在组织-植入物界面处的M2巨噬细胞百分比增加,而M1巨噬细胞百分比降低。这些变化与植入物周围纤维化囊的形成减少和下游组织整合改善有关。这项研究的结果证明了一种通用的细胞因子递送系统,可用于转移不可降解物质的组织-植入物界面的早期巨噬细胞极化,并建议在宿主反应早期调节先天免疫反应可能是一种优选的方法。促进生物材料整合和成功的战略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号